Home › Trial NCT04997993
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
- Trial IDNCT04997993
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorDeborah Doroshow
- Enrollment23
- Start date2023-12-13
- ConditionsPTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.